Clinical Trial Update: Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase II randomized trial is evaluating short-term darolutamide in combination with radiation therapy for patients with intermediate unfavourable risk prostat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Nubeqa (darolutamide)

Snippet

Sponsor: Institut Bergonié | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING